newsfilter
← Latest News
Business Wire·

Faruqi & Faruqi, LLP Launches an Investigation against ImmunoCellular Therapeutics, Ltd. (IMUC) for Potential Breaches of Fiduciary Duties by Its Board of Directors

NEW YORK--(BUSINESS WIRE)--Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (NYSE MKT: IMUC) for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders’ approval for an amendment of the Company’s 2006 Equity Incentive Plan.